unapproved glp-1 weight-loss drugs

unapproved glp-1 weight-loss drugs

5 Lethal GLP‑1 / Weight‑Loss Drugs You Must Avoid?

Over 20,000 patients have stopped GLP-1 weight-loss treatments, leading the FDA to tighten oversight of these drugs. The agency now demands long-term safety data, flags unapproved products that bypass clinical safeguards, and is investigating why so many people discontinue therapy. Medical Disclaimer: This article is for informational purposes only